News: Companies and Markets
Latest in Companies and Markets
Pfizer has agreed to acquire FoldRx Pharmaceuticals to further its interest in rare and orphan diseases, including CNS diseases.
02 September 2010
Elite Acquires Generic Naltrexone
02 September 2010
02 September 2010
US Awards Biothreat Antibiotic Contract
01 September 2010
01 September 2010
BioMarin Receives Orphan Drug Designation for Pompe Disease Drug
01 September 2010
01 September 2010
Novartis Lands Major Stake in Eye Care Company Alcon
27 August 2010
27 August 2010
Takeda's Actos Poses the Same Risks as Avandia, Says Study
27 August 2010
27 August 2010
GlaxoSmithKline Begins Phase III Trials of Shingles Vaccine
27 August 2010
27 August 2010
Somaxon Boosted by Procter & Gamble Deal
26 August 2010
26 August 2010
Fibromyalgia Drug Rejected Amid Date-Rape Fears
23 August 2010
23 August 2010
US Announces Sweeping Review of Medical Countermeasures
20 August 2010
20 August 2010
